Racial and ethnic disparities in rheumatoid arthritis

Current Rheumatology Reports

Volumn 14, Issue 5, 2012, Pages 463-471

  McBurney, Christine A ^a   Vina, Ernest R ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Arthritis Research Center   (United States)

Author keywords

Adherence; Depression; Ethnicity; Health disparities; Health literacy; Patient provider communication; Race; Rheumatoid arthritis; Socioeconomic status; Treatment

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; ATTITUDE TO ILLNESS; DEPRESSION; DISEASE ASSOCIATION; DOCTOR PATIENT RELATION; ETHNICITY; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HEALTH DISPARITY; HEALTH LITERACY; HUMAN; MEDICARE; PATIENT COMPLIANCE; PATIENT PREFERENCE; PRESCRIPTION; PRIVATE PRACTICE; PUBLIC HEALTH SERVICE; RHEUMATOID ARTHRITIS; SOCIAL STATUS; THERAPY DELAY; TREATMENT OUTCOME; TRUST;

ARTHRITIS, RHEUMATOID; COMORBIDITY; DEPRESSION; ETHNIC GROUPS; HEALTH CARE SURVEYS; HEALTH COMMUNICATION; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84869238471     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-012-0276-0     Document Type: Article

References (81)

1. Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I. Arthritis Rheum. 2008; 58: 15-25.
2. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising? results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010; 62: 1576-82.
3. Birnbaum H, Pike C, Kaufman R, Marynchenko M, Kidolezi Y, Cifaldi M. Societal cost of rheumatoid arthritis patients in the US. Curr Med Res Opin. 2010; 26: 77-90.
4. Simons WR, Rosenblatt LC, Trivedi DN. The economic consequences of rheumatoid arthritis: analysis of Medical Expenditure Panel Survey 2004, 2005, and 2006 data. J Occup Environ Med. 2012; 54: 48-55.
5. Jantti J, Aho K, Kaarela K, Kautiainen H. Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study. Rheumatology (Oxford). 1999; 38: 1138-41. (Pubitemid 29537337)
6. Sokka T, Kautiainen H, Mottonen T, Hannonen P. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol. 1999; 26: 1681-5. (Pubitemid 29367305)
7. Barrett EM, Scott DG, Wiles NJ, Symmons DP. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology (Oxford). 2000; 39: 1403-9. (Pubitemid 32045868)
8. Eberhardt K, Larsson BM, Nived K, Lindqvist E. Work disability in rheumatoid arthritis - development over 15 years and evaluation of predictive factors over time. J Rheumatol. 2007; 34: 481-7. (Pubitemid 46364001)
9. Theis KA, Murphy L, Hootman JM, Helmick CG, Yelin E. Prevalence and correlates of arthritis-attributable work limitation in the US population among persons ages 18-64: 2002 National Health Interview Survey data. Arthritis Rheum. 2007; 57: 355-63. (Pubitemid 46682521)
10. 106th Congress. S. 1880 - 106th Congress: Minority Health and Health Disparities Research and Education Act of 2000. Available from: http: // www.govtrack.us/congress/bills/106/s1880; April 16, 2012.
11. Thomson GE,Mitchell F,WilliamsM, editors. Examining the Health Disparities Research Plan of the National Institutes of Health: unfinished business. Washington: The National Academies Press; 2006.
12. Healthy People 2010 final review - complete review. Available from: http: //www.cdc.gov/nchs/data/hpdata2010/hp2010-final- review.pdf; April 16, 2012. This final review of the 2000-2010 decade of the Healthy People initiative reveals the national importance of health disparities in a wide range of conditions and provides data regarding ongoing inequalities in care, morbidity, and mortality in racial/ethnic minorities.
13. Smedley BD, Stith AY, Nelson AR, editors. Unequal treatment: confronting racial and ethnic disparities in health care. Washington: The National Academies Press; 2002.
14. Bridges Jr SL, Hughes LB, Mikuls TR, et al. Early rheumatoid arthritis in African-Americans: the CLEAR Registry. Clin Exp Rheumatol. 2003; 21 Suppl 31: S138-45. (Pubitemid 37265603)
15. Zhang J, Redden DT, McGwin Jr G, et al. Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2010; 62: 2219-26.
16. Mikuls TR, Saag KG, Curtis J, et al. Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data. J Natl Med Assoc. 2005; 97: 1155-60. (Pubitemid 41098543)
17. Hughes LB, Morrison D, Kelley JM, et al. The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis Rheum. 2008; 58: 349-58. (Pubitemid 351294869)
18. Hughes LB, Reynolds RJ, Brown EE, et al. Most common singlenucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans. Arthritis Rheum. 2010; 62: 3547-53.
19. Burgos PI, Causey ZL, Tamhane A, et al. Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis. Arthritis Res Ther. 2010; 12: R75.
20. Bridges Jr SL, Causey ZL, Burgos PI, et al. Radiographic severity of rheumatoid arthritis in African Americans: results from a multicenter observational study. Arthritis Care Res (Hoboken). 2010; 62: 624-31.
21. Mikuls TR, Levan T, Gould KA, et al. Impact of interactions of cigarette smokingwith NAT2 polymorphisms on rheumatoid arthritis risk in African Americans. Arthritis Rheum. 2012; 64: 655-64.
22. House JS. Understanding social factors and inequalities in health: 20th century progress and 21st century prospects. J Health Soc Behav. 2002; 43: 125-42.
23. Schmajuk G, Trivedi AN, Solomon DH, et al. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. JAMA. 2011; 305: 480-6. This national report of the Medicare HEDIS RA measure revealed lower rates of DMARD receipt in RA Medicare patients who were male, nonwhite, and of low socioeconomic status.
24. Bruce B, Fries JF, Murtagh KN. Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol. 2007; 34: 1475-9. (Pubitemid 47067981)
25. Suarez-Almazor ME, Berrios-Rivera JP, Cox V, Janssen NM, Marcus DM, Sessoms S. Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis. J Rheumatol. 2007; 34: 2400-7. (Pubitemid 350230662)
26. Kyburz D, Gabay C, Michel BA, Finckh A. The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. Rheumatology (Oxford). 2011; 50: 1106-10.
27. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford). 2004; 43: 906-14. (Pubitemid 38996967)
28. Lard LR, Visser H, Speyer I, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med. 2001; 111: 446-51. (Pubitemid 33016415)
29. Finckh A, Bansback N, Marra CA, et al. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Ann Intern Med. 2009; 151: 612-21.
30. Barton JL, Trupin L, Schillinger D, et al. Racial and ethnic disparities in disease activity and function among persons with rheumatoid arthritis from university-affiliated clinics. Arthritis Care Res (Hoboken). 2011; 63: 1238-46. This article highlights the concept that disparities in care are influenced by both race/ ethnicity and clinical care location (university vs. public clinic). At the university clinic, white patients had decreased disease activity and disability and were more likely to be prescribed a biologic agent than were nonwhite, non-English-speaking, and/or immigrant patients. Patients at the public clinic overall had higher disease activity, but the racial/ethnic disparities between groups were not apparent.
31. Bruce B, Fries JF. Rheumatologist perceptions of sources of health care disparities in minority rheumatoid arthritis patients. J Clin Rheumatol. 2009; 15: 145-7.
32. Harrison MJ, Farragher TM, Clarke AM, Manning SC, Bunn DK, Symmons DP. Association of functional outcome with both personaland area-level socioeconomic inequalities in patients with inflammatory polyarthritis. Arthritis Rheum. 2009; 61: 1297-304.
33. Callahan LF, Cleveland RJ, Li X, et al. Current social position associated with rheumatoid arthritis severity and self-reported health outcomes in African Americans. Arthritis Rheum. 2011; 63 Suppl 10: 1545.
34. Cleveland RJ, Schwartz TA, Jonas BL, et al. Influence of lifecourse social position on rheumatoid arthritis disease severity in African Americans. Arthritis Rheum. 2011; 63 Suppl 10: 2642.
35. Carter C, Changolkar A, Scott McKenzie R. Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients. J Med Econ. 2011.
36. Wolfe F, Michaud K. Out-of-pocket expenses and their burden in patients with rheumatoid arthritis. Arthritis Rheum. 2009; 61: 1563-70.
37. Karaca-Mandic P, Joyce GF, Goldman DP, Laouri M. Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res. 2010; 45: 1227-50.
38. Beard AJ, Sleath B, Blalock SJ, et al. Predictors of rheumatoid arthritis patient-physician communication about medication costs during visits to rheumatologists. Arthritis Care Res (Hoboken). 2010; 62: 632-9.
39. Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient-physician relationship. JAMA. 1999; 282: 583-9. (Pubitemid 29380298)
40. Johnson RL, Roter D, Powe NR, Cooper LA. Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health. 2004; 94: 2084-90. (Pubitemid 39578411)
41. Constantinescu F, Goucher S, Weinstein A, Fraenkel L. Racial disparities in treatment preferences for rheumatoid arthritis. Med Care. 2009; 47: 350-5. This article explores the relationship of race to treatment preferences in RA. Fewer African-American patients preferred aggressive therapy, as compared with white patients with the same disease activity.
42. Constantinescu F, Goucher S, Weinstein A, Smith W, Fraenkel L. Understanding why rheumatoid arthritis patient treatment preferences differ by race. Arthritis Rheum. 2009; 61: 413-8. The authors explored racial differences in treatment preferences by studying the decision making behind the trade-offs patients made between the theoretical risks/benefits of RA therapies. They determined that a greater proportion of white patients were concerned with likelihood of benefit, while a greater proportion of African- Americans were concerned with the risks of toxicity.
43. Salt E, Frazier SK. Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature. Orthop Nurs. 2010; 29: 260-75.
44. Garcia-Gonzalez A, Richardson M, Garcia Popa-Lisseanu M, et al. Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol. 2008; 27: 883-9.
45. Garcia Popa-Lisseanu MG, Greisinger A, Richardson M, et al. Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol. 2005; 32: 913-9. (Pubitemid 40676504)
46. Cannon GW, Mikuls TR, Hayden CL, et al. Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice. Arthritis Care Res (Hoboken). 2011; 63: 1680-90. This Veterans Affairs study linked the lower doses of methotrexate actually taken by those with low medication adherence (vs. high medication adherence) with increased disease activity. African-American patients were more likely to be in the low-adherence group.
47. van den Bemt BJ, den Broeder AA, van den Hoogen FH, et al. Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis. Scand J Rheumatol. 2011; 40: 192-6.
48. Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect. 2004; 7: 235-45. (Pubitemid 39166372)
49. Hall MA, Dugan E, Zheng B, Mishra AK. Trust in physicians and medical institutions: what is it, can it be measured, and does it matter? Milbank Q. 2001; 79: 613-39. (Pubitemid 33636207)
50. Thom DH, Campbell B. Patient-physician trust: an exploratory study. J Fam Pract. 1997; 44: 169-76. (Pubitemid 27087652)
51. Hall MA, Camacho F, Dugan E, Balkrishnan R. Trust in the medical profession: conceptual and measurement issues. Health Serv Res. 2002; 37: 1419-39. (Pubitemid 35398466)
52. Thom DH, Kravitz RL, Bell RA, Krupat E, Azari R. Patient trust in the physician: relationship to patient requests. Fam Pract. 2002; 19: 476-83. (Pubitemid 35244232)
53. O'Malley AS, Sheppard VB, Schwartz M, Mandelblatt J. The role of trust in use of preventive services among low-income African- American women. Prev Med. 2004; 38: 777-85. (Pubitemid 38757527)
54. Safran DG, Taira DA, Rogers WH, Kosinski M, Ware JE, Tarlov AR. Linking primary care performance to outcomes of care. J Fam Pract. 1998; 47: 213-20. (Pubitemid 28433696)
55. Parchman ML, Burge SK. The patient-physician relationship, primary care attributes, and preventive services. Fam Med. 2004; 36: 22-7. (Pubitemid 38063906)
56. Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med. 2004; 19: 1096-103. (Pubitemid 39552579)
57. Keating NL, Gandhi TK, Orav EJ, Bates DW, Ayanian JZ. Patient characteristics and experiences associated with trust in specialist physicians. Arch Intern Med. 2004; 164: 1015-20. (Pubitemid 38581523)
58. Berrios-Rivera JP, Street Jr RL, Garcia Popa-Lisseanu MG, et al. Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 2006; 55: 385-93. (Pubitemid 43887024)
59. Dewalt DA, Berkman ND, Sheridan S, Lohr KN, Pignone MP. Literacy and health outcomes: a systematic review of the literature. J Gen Intern Med. 2004; 19: 1228-39. (Pubitemid 40041388)
60. Swearingen CJ, McCollum L, Daltroy LH, Pincus T, Dewalt DA, Davis TC. Screening for low literacy in a rheumatology setting: more than 10% of patients cannot read "cartilage," "diagnosis," "rheumatologist, " or "symptom". J Clin Rheumatol. 2010; 16: 359-64.
61. Hirsh JM, Gardner EM. A pilot study to determine whether patients are likely to understand the educational information available on-line about arthritic disorders. J Clin Rheumatol. 2009; 15: 367-8.
62. Hirsh JM, Boyle DJ, Collier DH, et al. Limited health literacy is a common finding in a public health hospital's rheumatology clinic and is predictive of disease severity. J Clin Rheumatol. 2011; 17: 236-41. In this article, the authors found elevated levels of limited health literacy in racial/ethnic minorities versus whites at a public health hospital's rheumatology clinic. Limited health literacy in this population was independently correlated with functional disability.
63. Rudd RE, Blanch DC, Gall V, et al. A randomized controlled trial of an intervention to reduce low literacy barriers in inflammatory arthritis management. Patient Educ Couns. 2009; 75: 334-9.
64. Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med. 2002; 64: 52-60. (Pubitemid 34137399)
65. Katz PP, Yelin EH. Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J Rheumatol. 1993; 20: 790-6. (Pubitemid 23158471)
66. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000; 160: 2101-7. (Pubitemid 30482715)
67. Treharne GJ, Lyons AC, Kitas GD. Suicidal ideation in patients with rheumatoid arthritis: research may help identify patients at high risk. BMJ. 2000; 321: 1290.
68. Fuller-Thomson E, Shaked Y. Factors associated with depression and suicidal ideation among individuals with arthritis or rheumatism: findings from a representative community survey. Arthritis Rheum. 2009; 61: 944-50.
69. Ang DC, Choi H, Kroenke K, Wolfe F. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol. 2005; 32: 1013-9. (Pubitemid 40828071)
70. Escalante A, del Rincon I, Mulrow CD. Symptoms of depression and psychological distress among Hispanics with rheumatoid arthritis. Arthritis Care Res. 2000; 13: 156-67.
71. Margaretten M, Yelin E, Imboden J, et al. Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis. Arthritis Rheum. 2009; 61: 1586-91.
72. Margaretten M, Barton J, Julian L, et al. Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2011; 63: 240-6. In this study, the authors investigated the relationship between RA, depression, race, socioeconomic status, site of health care, and function in RA patients at two clinics (university and public). Depressed RA patients were more likely to be a member of a racial/ethnic minority group, attend the public clinic, not be on a DMARD, and have increased functional disability.
73. Cook A, Grothaus CT, Gutierrez CE, Kehoe KA, Valentin MR. Closing the gap "Disparity in native Hawaiian cardiac care.". Hawaii Med J. 2010; 69 Suppl 2: 7-10.
74. Chen LM, Li G, Reitzel LR, et al. Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. Cancer Prev Res (Phila). 2009; 2: 782-91.
75. Wagner EH. The role of patient care teams in chronic disease management. BMJ. 2000; 320: 569-72. (Pubitemid 30175806)
76. Staten LK, Cutshaw CA, Davidson C, Reinschmidt K, Stewart R, Roe DJ. Effectiveness of the Pasos Adelante chronic disease prevention and control program in a US-Mexico border community, 2005-2008. Prev Chronic Dis. 2012; 9: E08.
77. O'Brien MJ, Halbert CH, Bixby R, Pimentel S, Shea JA. Community health worker intervention to decrease cervical cancer disparities in Hispanic women. J Gen Intern Med. 2010; 25: 1186-92.
78. Holt CL,Wynn TA, Litaker MS, Southward P, Jeames S, Schulz E. A comparison of a spiritually based and non-spiritually based educational intervention for informed decision making for prostate cancer screening among church-attending African-American men. Urol Nurs. 2009; 29: 249-58.
79. Kenya S, Chida N, Symes S, Shor-Posner G. Can community health workers improve adherence to highly active antiretroviral therapy in the USA? A review of the literature. HIV Med. 2011; 12: 525-34.
80. Esselens G, Westhovens R, Verschueren P. Effectiveness of an integrated outpatient care programme compared with present-day standard care in early rheumatoid arthritis. Musculoskelet Care. 2009; 7: 1-16.
81. Vliet Vlieland TP, Hazes JM. Efficacy of multidisciplinary team care programs in rheumatoid arthritis. Semin Arthritis Rheum. 1997; 27: 110-22. (Pubitemid 27461156)